|
1
|
Fan J, Wu Y, Yuan M, Page D, Liu J, Ong
IM, Peissig P and Burnside E: Structure-leveraged methods in breast
cancer risk prediction. J Mac Learn Res. 17:852017.
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robinson SP and Jordan VC: Antiestrogenic
action of toremifene on hormone-dependent, -independent, and
heterogeneous breast tumor growth in the athymic mouse. Cancer Res.
49:1758–1762. 1989.PubMed/NCBI
|
|
4
|
Wu CW, Liu HC, Yu YL, Hung YT, Wei CW and
Yiang GT: Combined treatment with vitamin C and methotrexate
inhibits triple-negative breast cancer cell growth by increasing
H2O2 accumulation and activating caspase-3
and p38 pathways. Oncol Rep. 37:2177–2184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yu YL, Chou RH, Liang JH, Chang WJ, Su KJ,
Tseng YJ, Huang WC, Wang SC and Hung MC: Targeting the EGFR/PCNA
signaling suppresses tumor growth of triple-negative breast cancer
cells with cell-penetrating PCNA peptides. PLoS One. 8:e613622013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Metzger-Filho O, Tutt A, de Azambuja E,
Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA Jr, Ellis
P, et al: Dissecting the heterogeneity of triple-negative breast
cancer. J Clin Oncol. 30:1879–1887. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Williams CB, Soloff AC, Ethier SP and Yeh
ES: Perspectives on epidermal growth factor receptor regulation in
triple-negative breast cancer: Ligand-mediated mechanisms of
receptor regulation and potential for clinical targeting. Adv
Cancer Res. 127:253–281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Malaviya AN: Low-dose methotrexate
(LD-MTX) in rheumatology practice-a most widely misunderstood drug.
Curr Rheumatol Rev. 12:168–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Robien K, Boynton A and Ulrich CM:
Pharmacogenetics of folate-related drug targets in cancer
treatment. Pharmacogenomics. 6:673–689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mori S, Hidaka M, Kawakita T, Hidaka T,
Tsuda H, Yoshitama T, Migita K and Ueki Y: Factors associated with
myelosuppression related to low-dose methotrexate therapy for
inflammatory rheumatic diseases. PLoS One. 11:e01547442016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maejima H, Watarai A, Nakano T, Katayama
C, Nishiyama H and Katsuoka K: Adverse effects of methotrexate in
three psoriatic arthritis patients. Rheumatol Int. 34:571–574.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kolli VK, Abraham P, Isaac B and
Selvakumar D: Neutrophil infiltration and oxidative stress may play
a critical role in methotrexate-induced renal damage. Chemotherapy.
55:83–90. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cağlar Y, Özgür H, Matur I, Yenilmez ED,
Tuli A, GÖnlüşen G and Polat S: Ultrastructural evaluation of the
effect of N-acetylcysteine on methotrexate nephrotoxicity in rats.
Histol Histopathol. 28:865–874. 2013.PubMed/NCBI
|
|
15
|
Yang W, Zou Y, Meng F, Zhang J, Cheng R,
Deng C and Zhong Z: Efficient and targeted suppression of human
lung tumor xenografts in mice with methotrexate sodium encapsulated
in all-function-in-one chimeric polymersomes. Adv Mater.
28:8234–8239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Larsen EC, Devidas M, Chen S, Salzer WL,
Raetz EA, Loh ML, Mattano LA Jr, Cole C, Eicher A, Haugan M, et al:
Dexamethasone and high-dose methotrexate improve outcome for
children and young adults with high-risk B-acute lymphoblastic
leukemia: A report from children's oncology group study AALL0232. J
Clin Oncol. 34:2380–2388. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kansara R, Shenkier TN, Connors JM, Sehn
LH, Savage KJ, Gerrie AS and Villa D: Rituximab with high-dose
methotrexate in primary central nervous system lymphoma. Am J
Hematol. 90:1149–1154. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cipolleschi MG, Marzi I, Rovida E,
Olivotto M and Dello Sbarba P: Low-dose methotrexate enhances
cycling of highly anaplastic cancer cells. Cell Cycle. 16:280–285.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yiang GT, Chou PL, Hung YT, Chen JN, Chang
WJ, Yu YL and Wei CW: Vitamin C enhances anticancer activity in
methotrexate-treated Hep3B hepatocellular carcinoma cells. Oncol
Rep. 32:1057–1063. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barros S, Mencia N, Rodriguez L, Oleaga C,
Santos C, Noé V and Ciudad CJ: The redox state of cytochrome c
modulates resistance to methotrexate in human MCF7 breast cancer
cells. PLoS One. 8:e632762013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tanabe M: Combination chemotherapy of
mitomycin C and methotrexate was effective on metastatic breast
cancer resistant to Eribulin, Vinorelbine, and bevacizumab after
anthracycline, Taxane, and Capecitabine. Case Rep Oncol. 9:422–426.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Velthuis-te Wierik EJ, van den Berg H,
Weststrate JA, van het Hof KH and de Graaf C: Consumption of
reduced-fat products: Effects on parameters of anti-oxidative
capacity. Eur J Clin Nutr. 50:214–219. 1996.PubMed/NCBI
|
|
23
|
Smolarek AK, So JY, Burgess B, Kong AN,
Reuhl K, Lin Y, Shih WJ, Li G, Lee MJ, Chen YK, et al: Dietary
administration of δ- and γ-tocopherol inhibits tumorigenesis in the
animal model of estrogen receptor-positive, but not HER-2 breast
cancer. Cancer Prev Res. 5:1310–1320. 2012. View Article : Google Scholar
|
|
24
|
Constantinou C, Papas A and Constantinou
AI: Vitamin E and cancer: An insight into the anticancer activities
of vitamin E isomers and analogs. Int J Cancer. 123:739–752. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smolarek AK and Suh N: Chemopreventive
activity of vitamin E in breast cancer: A focus on γ- and
δ-tocopherol. Nutrients. 3:962–986. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zapata GL, Guajardo MH and Terrasa AM: The
in vitro protective effect of alpha-tocopherol on oxidative injury
in the dog retina. Vet J. 177:266–272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ekstrand-Hammarstrom B, Osterlund C,
Lilliehöök B and Bucht A: Vitamin E down-modulates
mitogen-activated protein kinases, nuclear factor-kappaB and
inflammatory responses in lung epithelial cells. Clin Exp Immunol.
147:359–369. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Comitato R, Nesaretnam K, Leoni G, Ambra
R, Canali R, Bolli A, Marino M and Virgili F: A novel mechanism of
natural vitamin E tocotrienol activity: Involvement of ERbeta
signal transduction. Am J Physiol Endocrinol Metab. 297:E427–E437.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chamras H, Barsky SH, Ardashian A,
Navasartian D, Heber D and Glaspy JA: Novel interactions of vitamin
E and estrogen in breast cancer. Nutr Cancer. 52:43–48. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao Y, Qi X, Zheng Y, Ji H, Wu L, Zheng N
and Tang J: Nanoemulsion enhances α-tocopherol succinate
bioavailability in rats. Int J Pharm. 515:506–514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kulikov AV, Vdovin AS, Zhivotovsky B and
Gogvadze V: Targeting mitochondria by α-tocopheryl succinate
overcomes hypoxia-mediated tumor cell resistance to treatment. Cell
Mol Life Sci. 71:2325–2333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Angulo-Molina A, Reyes-Leyva J, López-Malo
A and Hernández J: The role of alpha tocopheryl succinate (α-TOS)
as a potential anticancer agent. Nutr Cancer. 66:167–176. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu W, Liao QY, Hantash FM, Sanders BG and
Kline K: Activation of extracellular signal-regulated kinase and
c-Jun-NH2-terminal kinase but not p38 mitogen-activated
protein kinases is required for RRR-α-tocopheryl succinate-induced
apoptosis of human breast cancer cells. Cancer Res. 61:6569–6576.
2001.PubMed/NCBI
|
|
34
|
Badr DM, Hafez HF, Agha AM and Shouman SA:
The combination of α-tocopheryl succinate and sodium selenite on
breast cancer: A merit or a demerit? Oxid Med Cell Longev 2016.
47416942016.
|
|
35
|
Wang XF, Xie Y, Wang HG, Zhang Y, Duan XC
and Lu ZJ: α-Tocopheryl succinate induces apoptosis in
erbB2-expressing breast cancer cell via NF-κB pathway. Acta
Pharmacol Sin. 31:1604–1610. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang D, Chuang HC, Weng SC, Huang PH,
Hsieh HY, Kulp SK and Chen CS: alpha-Tocopheryl succinate as a
scaffold to develop potent inhibitors of breast cancer cell
adhesion. J Med Chem. 52:5642–5648. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Turley JM, Fu T, Ruscetti FW, Mikovits JA,
Bertolette DC III and Birchenall-Roberts MC: Vitamin E succinate
induces Fas-mediated apoptosis in estrogen receptor-negative human
breast cancer cells. Cancer Res. 57:881–890. 1997.PubMed/NCBI
|
|
38
|
Lin BR, Yu CJ, Chen WC, Lee HS, Chang HM,
Lee YC, Chien CT and Chen CF: Green tea extract supplement reduces
D-galactosamine-induced acute liver injury by inhibition of
apoptotic and proinflammatory signaling. J Biomed Sci. 16:352009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yiang GT, Yu YL, Lin KT, Chen JN, Chang WJ
and Wei CW: Acetaminophen induces JNK/p38 signaling and activates
the caspase-9-3-dependent cell death pathway in human mesenchymal
stem cells. Int J Mol Med. 36:485–492. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Abe N, Shimizu T, Miyoshi N, Murata Y and
Nakamura Y: α-Tocopherol sensitizes human leukemia HL-60 cells to
apoptosis induced by benzyl isothiocyanate. Biosci Biotechnol
Biochem. 76:381–383. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Abo-Haded HM, Elkablawy MA, Al-Johani Z,
Al-Ahmadi O and El-Agamy DS: Hepatoprotective effect of sitagliptin
against methotrexate induced liver toxicity. PLoS One.
12:e01742952017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Peh HY, Tan WS, Liao W and Wong WS:
Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol.
Pharmacol Ther. 162:152–169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yüncü M, Bükücü N, Bayat N, Sencar L and
Tarakcioglu M: The effect of vitamin E and L-carnitine against
methotrexate-induced injury in rat testis. Turk J Med Sci.
45:517–525. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pyrhönen S, Kuitunen T, Nyandoto P and
Kouri M: Randomised comparison of fluorouracil, epidoxorubicin and
methotrexate (FEMTX) plus supportive care with supportive care
alone in patients with non-resectable gastric cancer. Br J Cancer.
71:587–591. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Drago JR, Nesbitt JA, Badalament RA and
Smith J: Chemotherapy and vitamin E in treatment of Nb rat prostate
tumors. In Vivo. 2:399–401. 1988.PubMed/NCBI
|
|
46
|
Fu JY, Htar TT, De Silva L, Tan DM and
Chuah LH: Chromatographic separation of vitamin E enantiomers.
Molecules. 22(pii): E2332017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dias MF, Sousa E, Cabrita S, Patricio J
and Oliveira CF: Chemoprevention of DMBA-induced mammary tumors in
rats by a combined regimen of alpha-tocopherol, selenium, and
ascorbic acid. Breast J. 6:14–19. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yiang GT, Chen JN, Lin PS, Liu HC, Chen SY
and Wei CW: Combined treatment with vitamin E and gefitinib has
synergistic effects to inhibit TGF-β1-induced renal fibroblast
proliferation. Mol Med Rep. 13:5372–5378. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Uchihara Y, Ueda F, Tago K, Nakazawa Y,
Ohe T, Mashino T, Yokota S, Kasahara T, Tamura H and Funakoshi-Tago
M: Alpha-tocopherol attenuates the anti-tumor activity of
crizotinib against cells transformed by NPM-ALK. PLoS One.
12:e01830032017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Peralta EA, Viegas ML, Louis S, Engle DL
and Dunnington GL: Effect of vitamin E on tamoxifen-treated breast
cancer cells. Surgery. 140:607–615. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chang H, Li C, Huo K, Wang Q, Lu L, Zhang
Q, Wang Y and Wang W: Luteolin prevents H2O2-induced apoptosis in
H9C2 cells through modulating Akt-P53/Mdm2 signaling pathway.
Biomed Res Int 2016. 51258362016.
|
|
52
|
Miyazato H, Taira J and Ueda K: Hydrogen
peroxide derived from marine peroxy sesquiterpenoids induces
apoptosis in HCT116 human colon cancer cells. Bioorg Med Chem Lett.
26:4641–4644. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang C, Wang G, Liu H and Hou YL:
Protective effect of bioactive compounds from Lonicera japonica
Thunb. Against H2O2-induced cytotoxicity using neonatal rat
cardiomyocytes. Iran J Basic Med Sci. 19:97–105. 2016.PubMed/NCBI
|
|
54
|
ElAttar TM and Virji AS: Inhibition of
growth in oral squamous carcinoma cells by cyclopentenone
prostaglandins: comparison with chemotherapeutic agents.
Prostaglandins Leukot Essent Fatty Acids. 56:461–465. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Alleva R, Benassi MS, Pazzaglia L,
Tomasetti M, Gellert N, Borghi B, Neuzil J and Picci P:
Alpha-tocopheryl succinate alters cell cycle distribution
sensitising human osteosarcoma cells to methotrexate-induced
apoptosis. Cancer Lett. 232:226–235. 2006. View Article : Google Scholar : PubMed/NCBI
|
